Lived Experiences of Patients with Advanced Pancreatic Cancer on Patient-reported Outcomes (PROs) Management: a Qualitative Phenomenological Study in Southwest China

Overview

Journal BMJ Open

Date 2025 Jan 29

PMID 39880447

Authors

Ping Chen

Wanting Hou

Changlin Li

Qingyue Liang

Li Ma

Xiumei Zhao

Cheng Yi

Affiliations

Soon will be listed here.

Abstract

Objectives: To explore the lived experiences of patients with advanced pancreatic cancer enrolled in a patient-reported outcomes (PROs) management programme and to preliminarily understand how PROs management influences various aspects of patient care and overall quality of life.

Design: A qualitative phenomenological study.

Setting: A national cancer care centre in Southwest China specialised in cancer care, with a comprehensive PROs management programme.

Participants: 15 participants diagnosed with advanced pancreatic cancer.

Results: Five key themes emerged from our interviews, including enhanced communication with healthcare providers, attributed to the structured nature of PROs; increased perceived sense of care, with patients feeling more valued and heard; PROs management facilitated better treatment decision-making, with patients feeling more involved and empowered; improved communication with family members, aiding in better understanding and support; and varied perceptions of the impact on quality of life, with some noting improvements in specific aspects like symptom management, while others were uncertain about the overall benefit.

Conclusions: PROs management plays a significant role in improving communication between patients with advanced pancreatic cancer and their healthcare providers, enhancing patients' involvement in treatment decisions, and potentially improving family dynamics. However, the impact of PROs management on the overall quality of life of patients remains complex and individualised. The findings suggest that further research with a more diverse patient population is needed to fully understand the implications of PROs management in advanced cancer care.

References

Caminiti C, Maglietta G, Diodati F, Puntoni M, Marcomini B, Lazzarelli S . The Effects of Patient-Reported Outcome Screening on the Survival of People with Cancer: A Systematic Review and Meta-Analysis. Cancers (Basel). 2022; 14(21). PMC: 9657884. DOI: 10.3390/cancers14215470. View

Tang C, Von Ah D, Fulton J . The Symptom Experience of Patients With Advanced Pancreatic Cancer: An Integrative Review. Cancer Nurs. 2017; 41(1):33-44. DOI: 10.1097/NCC.0000000000000463. View

Crafoord M, Fjell M, Sundberg K, Nilsson M, Langius-Eklof A . Engagement in an Interactive App for Symptom Self-Management during Treatment in Patients With Breast or Prostate Cancer: Mixed Methods Study. J Med Internet Res. 2020; 22(8):e17058. PMC: 7445604. DOI: 10.2196/17058. View

Xu Y, Liu W, Long Z, Wang L, Zhou M, Yin P . Mortality and years of life lost due to pancreatic cancer in China, its provinces, urban and rural areas from 2005 to 2020: results from the national mortality surveillance system. BMC Cancer. 2023; 23(1):893. PMC: 10512506. DOI: 10.1186/s12885-023-11258-7. View

Mizrahi J, Surana R, Valle J, Shroff R . Pancreatic cancer. Lancet. 2020; 395(10242):2008-2020. DOI: 10.1016/S0140-6736(20)30974-0. View

Assayag J, Kim C, Chu H, Webster J . The prognostic value of Eastern Cooperative Oncology Group performance status on overall survival among patients with metastatic prostate cancer: a systematic review and meta-analysis. Front Oncol. 2024; 13:1194718. PMC: 10757350. DOI: 10.3389/fonc.2023.1194718. View

Pouls B, Vriezekolk J, Bekker C, Linn A, van Onzenoort H, Vervloet M . Effect of Interactive eHealth Interventions on Improving Medication Adherence in Adults With Long-Term Medication: Systematic Review. J Med Internet Res. 2021; 23(1):e18901. PMC: 7822716. DOI: 10.2196/18901. View

Ellis L, Blanke C, Kohn E . Words matter: Restoring respect and dignity when referring to individuals with cancer. Cancer. 2017; 123(13):2390-2391. DOI: 10.1002/cncr.30625. View

Stabile C, Temple L, Ancker J, Basch E, Carter J, Miranda M . Ambulatory cancer care electronic symptom self-reporting (ACCESS) for surgical patients: a randomised controlled trial protocol. BMJ Open. 2019; 9(9):e030863. PMC: 6756418. DOI: 10.1136/bmjopen-2019-030863. View

10.

Sundler A, Lindberg E, Nilsson C, Palmer L . Qualitative thematic analysis based on descriptive phenomenology. Nurs Open. 2019; 6(3):733-739. PMC: 6650661. DOI: 10.1002/nop2.275. View

11.

He Y, Zhou X, Fan X, Zhang B, Ma L, Wu J . Disease Burden of Pancreatic Cancer - China, 1990-2019. China CDC Wkly. 2022; 4(24):527-531. PMC: 9257688. DOI: 10.46234/ccdcw2022.056. View

12.

Manrai M, Tilak T, Dawra S, Srivastava S, Singh A . Current and emerging therapeutic strategies in pancreatic cancer: Challenges and opportunities. World J Gastroenterol. 2021; 27(39):6572-6589. PMC: 8554408. DOI: 10.3748/wjg.v27.i39.6572. View

13.

Efficace F, Collins G, Cottone F, Giesinger J, Sommer K, Anota A . Patient-Reported Outcomes as Independent Prognostic Factors for Survival in Oncology: Systematic Review and Meta-Analysis. Value Health. 2021; 24(2):250-267. DOI: 10.1016/j.jval.2020.10.017. View

14.

Archer J, Stevenson L, Coulter A, Breen A . Connecting patient experience, leadership, and the importance of involvement, information, and empathy in the care process. Healthc Manage Forum. 2018; 31(6):252-255. DOI: 10.1177/0840470418783463. View

15.

Dai W, Zhang Y, Feng W, Liao X, Mu Y, Zhang R . Using patient-reported outcomes to manage postoperative symptoms in patients with lung cancer: protocol for a multicentre, randomised controlled trial. BMJ Open. 2019; 9(8):e030041. PMC: 6720560. DOI: 10.1136/bmjopen-2019-030041. View

16.

Okusaka T, Nakamura M, Yoshida M, Kitano M, Ito Y, Mizuno N . Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis. Int J Clin Oncol. 2023; 28(4):493-511. PMC: 10066137. DOI: 10.1007/s10147-023-02317-x. View

17.

Oh H, Seo W . Systematic review and meta-analysis of the correlates of cancer-related fatigue. Worldviews Evid Based Nurs. 2011; 8(4):191-201. DOI: 10.1111/j.1741-6787.2011.00214.x. View

18.

Tonini V, Zanni M . Pancreatic cancer in 2021: What you need to know to win. World J Gastroenterol. 2021; 27(35):5851-5889. PMC: 8475010. DOI: 10.3748/wjg.v27.i35.5851. View

19.

Sugimoto H, Kawashima H, Ohno E, Hayashi D, Kuwahara T, Morishima T . The prognostic factors and trajectory of HRQOL in patients with pancreatic cancer who received psychiatric intervention. J Gastroenterol Hepatol. 2015; 31(3):685-90. DOI: 10.1111/jgh.13172. View

20.

Health Commission Of The Peoples Republic Of China N . National guidelines for diagnosis and treatment of pancreatic cancer 2022 in China (English version). Chin J Cancer Res. 2022; 34(3):238-255. PMC: 9273582. DOI: 10.21147/j.issn.1000-9604.2022.03.05. View